Literature DB >> 7817505

Rapid diagnosis of equine influenza by the Directigen FLU-A enzyme immunoassay.

T M Chambers1, K F Shortridge, P H Li, D G Powell, K L Watkins.   

Abstract

The Directigen FLU-A enzyme immunoassay was tested for its ability to detect equine-2 influenza viruses in nasopharyngeal fluids from horses and ponies. A total of 125 swabs from experimental infections and from different sources of natural infection in the USA and Hong Kong were examined. The assay results were compared with the results of standard virus culture in embryonated chicken eggs or Madin-Darby canine kidney cells, and with the serology of the horses sampled. In comparison with virus culture the enzyme immunoassay exhibited 83 per cent sensitivity, 78 per cent specificity, 70 per cent positive predictive value and 88 per cent negative predictive value. The test appeared to be more sensitive than haemagglutination for the detection of low levels of virus in embryonated egg cultures. It also detected equine-1 influenza virus in culture. The test is rapid (15 minutes), simple, and should be a convenient method for the rapid diagnosis and screening of horses for equine influenza infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7817505     DOI: 10.1136/vr.135.12.275

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  8 in total

1.  Sialic acid species as a determinant of the host range of influenza A viruses.

Authors:  Y Suzuki; T Ito; T Suzuki; R E Holland; T M Chambers; M Kiso; H Ishida; Y Kawaoka
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Evaluation of the Directigen FluA+B test for rapid diagnosis of influenza virus type A and B infections.

Authors:  K H Chan; N Maldeis; W Pope; A Yup; A Ozinskas; J Gill; W H Seto; K F Shortridge; J S M Peiris
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

3.  Surveillance of equine respiratory viruses in Ontario.

Authors:  Andrés Diaz-Mendez; Laurent Viel; Joanne Hewson; Paul Doig; Susy Carman; Thomas Chambers; Ashish Tiwari; Catherine Dewey
Journal:  Can J Vet Res       Date:  2010-10       Impact factor: 1.310

4.  Development and evaluation of one-step TaqMan real-time reverse transcription-PCR assays targeting nucleoprotein, matrix, and hemagglutinin genes of equine influenza virus.

Authors:  Zhengchun Lu; Thomas M Chambers; Saikat Boliar; Adam J Branscum; Tracy L Sturgill; Peter J Timoney; Stephanie E Reedy; Lynn R Tudor; Edward J Dubovi; Mary Lynne Vickers; Stephen Sells; Udeni B R Balasuriya
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

5.  Comparison of sensitivities of virus isolation, antigen detection, and nucleic acid amplification for detection of equine influenza virus.

Authors:  Michelle Quinlivan; Ann Cullinane; Maura Nelly; Kees Van Maanen; Jacco Heldens; Sean Arkins
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

Review 6.  A Comprehensive Review on Equine Influenza Virus: Etiology, Epidemiology, Pathobiology, Advances in Developing Diagnostics, Vaccines, and Control Strategies.

Authors:  Raj K Singh; Kuldeep Dhama; Kumaragurubaran Karthik; Rekha Khandia; Ashok Munjal; Sandip K Khurana; Sandip Chakraborty; Yashpal S Malik; Nitin Virmani; Rajendra Singh; Bhupendra N Tripathi; Muhammad Munir; Johannes H van der Kolk
Journal:  Front Microbiol       Date:  2018-09-06       Impact factor: 5.640

7.  The evaluation of three diagnostic tests for the detection of equine influenza nucleoprotein in nasal swabs.

Authors:  Pamela Galvin; Sarah Gildea; Maura Nelly; Michelle Quinlivan; Sean Arkins; Cathal Walsh; Ann Cullinane
Journal:  Influenza Other Respir Viruses       Date:  2014-02-07       Impact factor: 4.380

8.  Evaluation of twenty-two rapid antigen detection tests in the diagnosis of Equine Influenza caused by viruses of H3N8 subtype.

Authors:  Takashi Yamanaka; Manabu Nemoto; Hiroshi Bannai; Koji Tsujimura; Takashi Kondo; Tomio Matsumura; Sarah Gildea; Ann Cullinane
Journal:  Influenza Other Respir Viruses       Date:  2016-02-01       Impact factor: 4.380

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.